The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
The purpose of this study was to assess efficacy, safety and PK in metastatic colorectal cancer (mCRC) given HLX208 (BRAF V600E inhibitor).
创建时间：
2022-03-15
